Cargando…
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198927/ https://www.ncbi.nlm.nih.gov/pubmed/35026842 http://dx.doi.org/10.1182/bloodadvances.2021005859 |
_version_ | 1784727750893895680 |
---|---|
author | Schimmer, Roman R. Kovtonyuk, Larisa V. Klemm, Nancy Fullin, Jonas Stolz, Sebastian M. Mueller, Jan Caiado, Francisco Kurppa, Kari J. Ebert, Benjamin L. Manz, Markus G. Boettcher, Steffen |
author_facet | Schimmer, Roman R. Kovtonyuk, Larisa V. Klemm, Nancy Fullin, Jonas Stolz, Sebastian M. Mueller, Jan Caiado, Francisco Kurppa, Kari J. Ebert, Benjamin L. Manz, Markus G. Boettcher, Steffen |
author_sort | Schimmer, Roman R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9198927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-91989272022-06-15 TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms Schimmer, Roman R. Kovtonyuk, Larisa V. Klemm, Nancy Fullin, Jonas Stolz, Sebastian M. Mueller, Jan Caiado, Francisco Kurppa, Kari J. Ebert, Benjamin L. Manz, Markus G. Boettcher, Steffen Blood Adv Research Letter American Society of Hematology 2022-05-27 /pmc/articles/PMC9198927/ /pubmed/35026842 http://dx.doi.org/10.1182/bloodadvances.2021005859 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
spellingShingle | Research Letter Schimmer, Roman R. Kovtonyuk, Larisa V. Klemm, Nancy Fullin, Jonas Stolz, Sebastian M. Mueller, Jan Caiado, Francisco Kurppa, Kari J. Ebert, Benjamin L. Manz, Markus G. Boettcher, Steffen TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms |
title | TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms |
title_full | TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms |
title_fullStr | TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms |
title_full_unstemmed | TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms |
title_short | TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms |
title_sort | tp53 mutations confer resistance to hypomethylating agents and bcl-2 inhibition in myeloid neoplasms |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198927/ https://www.ncbi.nlm.nih.gov/pubmed/35026842 http://dx.doi.org/10.1182/bloodadvances.2021005859 |
work_keys_str_mv | AT schimmerromanr tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms AT kovtonyuklarisav tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms AT klemmnancy tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms AT fullinjonas tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms AT stolzsebastianm tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms AT muellerjan tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms AT caiadofrancisco tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms AT kurppakarij tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms AT ebertbenjaminl tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms AT manzmarkusg tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms AT boettchersteffen tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms |